Manuel Castro Cabezas is a practicing internist-endocrinologist/vascular specialist. He joined Julius Clinical as scientific officer in September 2019.

Manuel was research fellow for the Netherlands Heart Foundation from 1989-1992 and earned his PhD-degree (cum laude) in 1993 at the University of Utrecht

He was resident Internal Medicine from 1992-1996 at the St. Antonius Hospital in Nieuwegein and from  1996-1997 at the UMC Utrecht. He registered in Internal Medicine in 1997 and was appointed senior scientist at the Lipoprotein Research Team from Professor Willem Erkelens at the UMC Utrecht. He registered in Endocrinology in 1998 and in Vascular Medicine in 2003.

At present he is, senior consultant Internal Medicine, Endocrinology, Diabetes and Vascular Medicine at the Franciscus Gasthuis & Vlietland in Rotterdam. He is chairman of the Thyroid Network South-West Netherlands. He is co-director of the Department of Endocrinology, Diabetes and Vascular Medicine FG&V. He is member of the Board of Endocrinology from the Dutch Society of Internal Medicine in the Netherlands. He received several grants from the Netherlands Heart Foundation, National Scientific Organization (NWO), Zon-MW, Coolsingel Foundation, and from several pharmaceutical companies. He has published over 200 papers in peer reviewed journals dealing with postprandial lipemia, diabetes, insulin resistance, obesity, metabolic syndrome, familial combined hyperlipidemia, HIV lipodystrophy and free fatty acid metabolism. He has published among others in the Journal of Clinical Investigation, Lancet, Annals of Internal Medicine, JACC, ATVB and Atherosclerosis. He was the first to describe the Complement-Lipid Pathway (CLiP), protected by several patents.

His network includes collaborations with different groups in the Netherlands (Erasmus MC in Rotterdam, UMC Leiden and UMC Utrecht), in Spain (Reus, Valencia, Málaga, Córdoba, Madrid), in Canada (University of Alberta, Edmonton) and in Australia (Perth). Dr. Castro Cabezas has participated in different international clinical trials in the fields of lipid management, diabetes and obesity. He has supervised 12 PhD students, several Post Docs and numerous postgraduate students. He is currently director of research at the department of Internal Medicine at FG&V with focus on “Inflammation and Atherosclerosis”.

He has initiated and supervised many different clinical trials (FRANCIS, REAL-CAD, LIVIT-D, DOSFEM, etc). He is editorial Board Member of: Clinica e Investigacion en Arteriosclerosis. Official Journal of the Spanish Atherosclerosis Society, the Latino-American Society of Atherosclerosis and the Ibero-Latin-American Society of Atherosclerosis and Editorial Board member of Atherosclerosis, official journal of the European Atherosclerosis Society and the International Atherosclerosis Society.